Remove Develop Remove Invest Remove Thousand Oaks
article thumbnail

Ocean Aero Gets Investment From Teledyne For Ocean Robots

socalTECH

San Diego-based Ocean Aero , a developer of unmanned, autonomous marine vehicles, has scored funding from Thousand Oaks-based Teledyne , the companies said this morning. Financial terms of the investment were not disclosed. According to Teledyne, the investment also included a strategic partnership deal.

article thumbnail

Amgen Re-Ups Investment In Sutro Biopharma

socalTECH

The venture capital arm of Thousand Oaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Amgen Acquires Firm For $1 Billion

socalTECH

Thousand Oaks-based biotech giant Amgen said Monday afternoon that it is acquiring Biovex , a Woburn, Massachusetts-based developer of treatments for melanoma and head and neck cancer. BioVex develops OncoVEX, a novel oncolytic vaccine in Phase 3 clinical development. READ MORE>>.

article thumbnail

Atara Biotherapeutics Gets $38.5M

socalTECH

Thousand Oaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M in a Series B funding round, for its efforts to develop treatments for patients with end-stage renal disease.

article thumbnail

Teledyne Buys Stake In Optech

socalTECH

Thousand Oaks-based Teledyne Technologies said this morning that it has acquired a minority stake in Optech , a developer of three dimensional, lidar-based imaging systems. Teledyne said the investment was made through its subsidiary, Teledyne DALSA. Financial details of the acquisition were not disclosed.

article thumbnail

Amgen Re-Ups On miRagen

socalTECH

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has re-upped on an investment in a biopharmaceuticals developing microRNA-based treatments for cardiovascular and muscle disease. and Broadview Ventures. miRagen is based in Boulder, Colorado.

article thumbnail

Atara Biotherapeutics Raises $52M

socalTECH

Thousand Oaks-based Atara Biotherapeutics announced this morning that it is in a second close of its Series B funding round, bringing its total raised in the funding to $52M. Atara is developing a number of biotherapeutics, including a treatment for protein energy wasting (PEW) and a treatment for ovarian cancer and other solid tumors.